pancreatic hormones (pharma 1+2) Flashcards

1
Q

out of the following which ones are chronic complications of diabetes.
Organ damage
muscle wasting
nephropathy, retinopahty, neuropathy
polyphagia, polypsia, polyuria.
ketonuria (common in type 1)
coronary artery/peripheral vascular disease
-impaired wound healing
Hyperglycemia, glucosuria
foot ulcer
-neurochemical imbalance (CNS)

A

organ damage
- nephropathy, retinopathy, neuropathy
-coronary artery/peripheral vascular disease
-impaired wound healing -foot ulcer
-neurochemical imbalance (CNS)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
1
Q

out of the following which ones are acute complications of diabetes.
Organ damage
muscle wasting
nephropathy, retinopahty, neuropathy
polyphagia, polypsia, polyuria.
ketonuria (common in type 1)
coronary artery/peripheral vascular disease
-impaired wound healing
Hyperglycemia, glucosuria
foot ulcer
-neurochemical imbalance (CNS)

A

Hyperglycemia, glucosuria
- ketonuria (common in type 1)
- polyphagia, polypsia, polyuria.
- muscle wasting

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

what is the insulin content in the body?

A

8 mg / 200 units

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

what is the insulin content in the body?

A

8 mg / 200 units

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

what’s the half life of insulin?

A

5 -7 mins

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

what is insulin?

A

acidic protein secreted by pancreatic beta cells

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

what are the subunits insulin is made of?

A

alpha and beta

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

insulin is connected by ?

A

c peptide and disulfide bonds

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

where is preproinsulin synthesized?

A

rER

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Preproinsulin is cleaved into …?

A

proinsulin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Proinsulin is transported where?

A

to golgi

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

in Golgi proinsulin is cleaved into C peptide and insulin by what?

A

membrane proteases

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

When a stimulus attaches to its receptor for insulin release, Beta granules will be exocytosed secreting what?

A

mostly insulin and C-peptide (90-97%) and proinsulin (3-4%).

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

what stimulates insulin secretion?

A

glucose
gh hormones
autonomic nts
pancreatic hormones

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

glucose mediated insulin secretion
st 1 ???????
st 2 glucose → G6P by hexokinase and enters TCA to generate ATP
st 3 ↑↑ ATP in cell will close K+ channels → depolarization
st 4 Ca+ influx through Ca+ channels → binds to calmodulin and activates PKA
5th: PKA activates myosin filaments→ promotes Beta granules migration and fusion on plasma membrane → exocytosis

A

glucose is taken up by GLUT2

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

glucose mediated insulin secretion
st 1 glucose is taken up by GLUT2
st 2 ???????????
st 3 ↑↑ ATP in cell will close K+ channels → depolarization
st 4 Ca+ influx through Ca+ channels → binds to calmodulin and activates PKA
5th: PKA activates myosin filaments→ promotes Beta granules migration and fusion on plasma membrane → exocytosis

A

glucose → G6P by hexokinase and enters TCA to generate ATP

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

glucose mediated insulin secretion
st 1 glucose is taken up by GLUT2
st 2 glucose → G6P by hexokinase and enters TCA to generate ATP
st 3 ??????????
st 4 Ca+ influx through Ca+ channels → binds to calmodulin and activates PKA
5th: PKA activates myosin filaments→ promotes Beta granules migration and fusion on plasma membrane → exocytosis

A

↑↑ ATP in cell will close K+ channels → depolarization

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

glucose mediated insulin secretion
st 1 glucose is taken up by GLUT2
st 2 glucose → G6P by hexokinase and enters TCA to generate ATP
st 3 ↑↑ ATP in cell will close K+ channels → depolarization
st 4 ???????????
5th: PKA activates myosin filaments→ promotes Beta granules migration and fusion on plasma membrane → exocytosis

A

Ca+ influx through Ca+ channels → binds to calmodulin and activates PKA

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

glucose mediated insulin secretion
st 1 glucose is taken up by GLUT2
st 2 glucose → G6P by hexokinase and enters TCA to generate ATP
st 3 ↑↑ ATP in cell will close K+ channels → depolarization
st 4 Ca+ influx through Ca+ channels → binds to calmodulin and activates PKA
5th: PKA activates myosin filaments→ promotes Beta granules migration and fusion on plasma membrane → exocytosis

A

PKA activates myosin filaments→ promotes Beta granules migration and fusion on plasma membrane → exocytosis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

what are the GI hormones that play a role in insulin secretion?

A

gastrin
secretin
VIP
GLP

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

what are the autonomic its involved in insulin secretion?

A

Ach
Epi
NE

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

………….→activation of PLC→Cleavage of Phosphatidyl inositol to IP3 (promotes Ca2+ from SR) and DAG (activates protein kinases)→stimulates insulin secretion

A

Ach binds to muscarinic receptors

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

Ach binds to muscarinic receptors→…………→Cleavage of Phosphatidyl inositol to IP3 (promotes Ca2+ from SR) and DAG (activates protein kinases)→stimulates insulin secretion

A

activation of PLC

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

Ach binds to muscarinic receptors→activation of PLC→……………→stimulates insulin secretion

A

Cleavage of Phosphatidyl inositol to IP3 (promotes Ca2+ from SR) and DAG (activates protein kinases)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Ach binds to muscarinic receptors→activation of PLC→Cleavage of Phosphatidyl inositol to IP3 (promotes Ca2+ from SR) and DAG (activates protein kinases)→.........
stimulates insulin secretion
24
..................→activation of Adenylyl cyclase→ generating cAMP from ATP→activation of protein kinases→promoting insulin secretion
Epinephrine binds to B2 adrenoceptors
25
Epinephrine binds to B2 adrenoceptors→................→ generating cAMP from ATP→activation of protein kinases→promoting insulin secretion
activation of Adenylyl cyclase
26
Epinephrine binds to B2 adrenoceptors→activation of Adenylyl cyclase→ ............→activation of protein kinases→promoting insulin secretion
generating cAMP from ATP
27
Epinephrine binds to B2 adrenoceptors→activation of Adenylyl cyclase→ generating cAMP from ATP→..................→promoting insulin secretion
activation of protein kinases
28
Epinephrine binds to B2 adrenoceptors→activation of Adenylyl cyclase→ generating cAMP from ATP→activation of protein kinases→..........
promoting insulin secretion
29
.............→promotes insulin secretion but activation of a2 adrenoceptors→inhibits insulin secretion
activation of B2 adrenoceptors
30
activation of B2 adrenoceptors→.....................→inhibits insulin secretion
promotes insulin secretion but activation of a2 adrenoceptors
31
activation of B2 adrenoceptors→promotes insulin secretion but activation of a2 adrenoceptors→.....................
inhibits insulin secretion
32
what are the pancreatic hormones involved in insulin secretion?
insulin glucagon somatostatin
33
role of insulin in insulin secretion
inhibit glucagon
34
role of glucagon in insulin secretion
activates insulin + somatostatin
35
role of somatostatin in insulin secretion
inhibit insulin and glucagon
36
where is insulin metabolized?
kidneys + liver
37
insulinase aka glutathione insulin transhydrogenase function
inactivates insulin by hydrolysis of insulin disulfide bonds →make insulin susceptible for degradation by cytosolic proteases into peptides and AAs
38
where is the insulin receptor found?
cell membrane
39
insulin binds to what SU on the receptor?
alpha
40
what happens when insulin binds to alpha subunit on receptor?
activate TK → phosphorylate beta SU and IRS1 → IRS1 receipt P13K → biological response
41
what is a key mediator in insulin pathway?
P13 kinase
42
Therapy / Glycemic goal of insulin: - To maintain FPG of 90 – 130 mg/dL = 5 mmol/L and ...
increasing energy expenditure increasing energy availability increasing metabolic insulin action = insulin pharmacodynamics by: 1. increasing # of insulin receptors and the affinity of insulin to its receptors increasing amount of intracellular mediators following the activation of insulin receptors - Primarily acts on liver, muscles, and heart.
43
what happens to carbs in the liver?
increase glycolysis + glycogenesis inhibit gluconeogenesis + glycogenolysis
44
what happens to fat in the liver?
increase lipogenesis inhibit lipolysis
45
what happens to proteins in the liver?
inhibit protein breakdown
46
what happens to carbs in muscle?
increase glucose uptake, glycolysis, glycogenesis
47
what happens to protein in muscle?
increase aa uptake and protein synthesis
48
what happens to carbs in adipose tissue?
increase glucose uptake and glycerol synthesis
49
what happens to fat in adipose tissue?
synthesis of TAG, FA Inhibit lipolysis
50
what does diabetic therapy depend on?
diet exercise pharmacotherapy
51
what are ROA of insulin?
subcutaneous injection ultrarapid / rapid can be even via IV useful against DKA insulin pump = continuous subcutaneous (regular or ultra rapid)
52
what pharmacotherapy is used in T1D?
insulin
53
what pharmacotherapy is used in T2D?
oral anti diabetics /insulin
54
what are the 7 insulin synthetics?
lisopro regular insulin = crystalline zinc insulin lente isophane (NPH) ultralente glargine
55
what is an ultra rapid insulin synthetic?
lisopro
56
what is a rapid insulin synthetic?
regular insulin aka crystalline insulin
57
what are the two intermediate insulin synthetics?
lente + NPH
57
what are the two intermediate insulin synthetics?
lente + NPH
58
what are the two long insulin synthetics?
ultralente + Glargine
59
when is lisopro taken?
few mins before meals
60
onset of lisopro
5 - 15 mins
61
when does lisopro peak?
45-75 mins
62
ROA of lisopro
IV
63
uses of lisopro
meals + acute hyperglycemia (DKA)
64
DOA of regular insulin
5-7 hrs
65
when is regular insulin taken?
30 mins before meals to control prandial blood glucose
66
onset of regular insulin
30 min to 1 hour
67
when does regular insulin peak?
2 - 4 hrs
68
how many times is regular insulin given?
3 times a day
69
what's the drug of choice in case of DKA?
regular insulin
70
lente onset
1 - 2 hours
71
lente peaks when
8-12 hours
72
uses of lente
basal insulin for overnight coverage
73
lente recommendation is to take it....
twice a day morning and night
74
isophane (NPH) insulin onset
1 - 2 hours
75
isophane peaks
8-12 hours
76
uses of isophane
basal insulin and for overnight coverage
77
isophane reccomendations
given twice a day morning and night
78
ultralente onset
4 - 8 hours
79
when does ultralente peak?
16-18 hours
80
ultralente usage
basal insulin + overnight coverage
81
ultralente should be taken...
1 dose per day
82
onset of glargine
2 hours
83
peak of glargine
it has no peak :P
84
uses of glargine
basal insulin + overnight coverage
85
glargine should be taken
once a day
86
what drug is less likely to cause hypoglycemia?
glargine
87
Lisopro peak coincides with postprandial hyperglycemia = best to control postprandial hyperglycemia § Ultralente has a wide peak and covers the whole day § Glargine rises at the beginning and then stays @ baseline level = less likely to develop hypoglycemia § Best combination to prevent hypoglycemia = Lisopro after each meal and Glargine once/day.
88
what decrease insulin?
alcohol and beta blockers
89
what physiological states affect daily insulin requirements?
pregnancy (increase) diabetogenic lifestyle (increase) chronic exercise (decrease)
90
what pathophysiological states affect daily insulin requirements?
surgery insulin resistance acute illness/infection (all increase)
91
what drug drug interactions affect daily insulin requirements?
glucocorticoids thiazide diuretics oral contraceptives (all increase)
92
what are the side effects of insulin?
hypoglycemia (major) lipodystrophy/lipohypertrophy insulin resistance = hyperinsulinemia urticaria + angioedema (less common now)
93
what are the main oral anti diabetic agents?
sulfonylureas meglitinides biguanides alpha glucosidase inhibitors thiaizolindinediones dipeptidyl peptidase IV inhibitors incretin mimetics SGLT2 inhibitors
94
what are the sulfonylureas?
tolbutamide chloropropamide glyburide glipizide glimipiride
95
what are the first generation sulfonylureas?
tolbutamide chloropropamide
96
what are the second generation sulfonylureas?
glyburide glipizide
97
what is a third generation sulfonylurea?
glimipiride
98
Chlorpropamide DOA
60 hours (longest of all sulfonylureas)
99
- Causes disulfiram effect due to accumulation of acetaldehyde by blocking aldehyde - Dilutional hyponatremia mostly seen w/ it. dehydrogenase
Chlorpropamide
100
Chlorpropamide
100
Second generation sulfonylureas - Has 16 to 24 hrs. duration of action - High potency - 50% excreted in feces (all other agents excreted in urine) - Less likely to cross the placenta → recommended during pregnancy
Glyburide
101
Second generation sulfonylureas - Has 12 to 24 hrs. duration of action - High potency
Glipizide:
102
Third generation sulfonylureas - Has >24 hrs. duration of action - High potency - Recommended for patients with cardiovascular diseases because it is the only drug that does NOT bind to the 140 subunit of the receptor, which is found on Beta cells and heart.
Glimipiride
103
Major MOA: acts on pancreas to improved glucose-mediated insulin secretion - glucagon secretion - Enhanced insulin secretion - Reduced hepatic insulin extraction Reduced
Sulfonylureas mechanism of action:
104
- - - Main SE = hypoglycemia * Increased hypoglycemia action of sulfonylureas if combined w/ other drugs that: o urinary excretion of sulfonylureas à its t1/2 o Displaces sulfonylureas from plasma proteins à activity o Inhibits CYP450 à sulfonylureas metabolism Dilutional hyponatremia = mostly seen in chlorpropamide due to ADH-like effect Hemolytic anemia and weight gain Disulfiram syndrome associated w/ tachycardia and hyperventilation due to inhibition of
Sulfonylureas side effects:
104
- - - Main SE = hypoglycemia * Increased hypoglycemia action of sulfonylureas if combined w/ other drugs that: o urinary excretion of sulfonylureas à its t1/2 o Displaces sulfonylureas from plasma proteins à activity o Inhibits CYP450 à sulfonylureas metabolism Dilutional hyponatremia = mostly seen in chlorpropamide due to ADH-like effect Hemolytic anemia and weight gain Disulfiram syndrome associated w/ tachycardia and hyperventilation due to inhibition of
Sulfonylureas side effects:
105
Acts like sulfonylureas - Has 4 to 6 hrs. duration of action = very short, peak=1 hr - MOA= block A TP sensitive K channels - Used to control postprandial hyperglycemia (less effect on FBG) - Mostly metabolized by liver - Minor renal excretion = good choice for patients w/ kidney disease - Useful replacement for patients w/ sulfa allergies
Meglitinides --> Repaglinide
106
Major MOA: * acts on liveràinhibit hepatic glucose output by inhibiting gluconeogenesis * Activity of insulin receptor (FBG by 20% and HbA1c by 1.5%) * Metabolic responses Decreases TG and FFA, small decrease in LDL, increase in HDL Duration= 6hrs, peak =2hrs Main excretion route is kidneys (unchanged) Excreted unchanged in the urine Rapidly absorbed in small intestine
Metformin
107
Side effects: * Major SEàNausea and vomiting * Interferes w/ Vit.B12 absorption * Lactic acidosisàdue to blockage of flow of acidic molecules through gluconeogenesis Contraindications: Any condition that predisposes the patient for metabolic acidosis = lactic acidosis * Hepatic diseases * Respiratory diseases * Renal diseases * CHF * Hypoxemia * Alcohol abuse
Metformin
108
Mainly acts on the GIT - Starch blockersàinhibits conversion of starch into glucoseàno absorption of glucose into systemic circulation - Does NOT cause hypoglycemiaàcan be taken w/out having diabetes
alpha glucosidase inhibitors - acarbose
109
Inhibits pancreatic alpha-amylase - Uses: control postprandial blood glucose - SEs: Diarrhea and abdominal discomfort because it stays in the GIT for long period of time Contraindications: inflammatory bowel disease and intestinal obstruction
alpha glucosidase inhibitors - acarbose
110
Mainly acts on muscles (max effect is 6-14 weeks) ↑↑Insulin sensitivity by activating: Peroxisome proliferator – activated receptor – gamma (PPyR)→ glucose utilization genes→ insulin sensitivity in muscles mainly, adipose tissue, and liver→ TGs, FFA, insulin, and glucose (i.e. as insulin sensitivity increases, insulin need decreases) FBG w/ moderate effect on postprandial glucose ↑↑CYP450 metabolism Contraindicated in liver and CHF disease SEs: mild anemia,sinusitis, bone loss, weight gain (subcutaneous not visceral), fluid retention
Thiazolindinediones 1. Rosiglitazone
110
Mainly acts on muscles (max effect is 6-14 weeks) ↑↑Insulin sensitivity by activating: Peroxisome proliferator – activated receptor – gamma (PPyR)→ glucose utilization genes→ insulin sensitivity in muscles mainly, adipose tissue, and liver→ TGs, FFA, insulin, and glucose (i.e. as insulin sensitivity increases, insulin need decreases) FBG w/ moderate effect on postprandial glucose ↑↑CYP450 metabolism Contraindicated in liver and CHF disease SEs: mild anemia,sinusitis, bone loss, weight gain (subcutaneous not visceral), fluid retention
Thiazolindinediones 1. Rosiglitazone
111
MOA:inhibits dipeptidyl peptidase→ ↑ GLP→ ↑glucose-mediated insulin secretion - rapid absorption in GIT, duration= 24hrs, peak= 1-4 hrs -Excreted unchanged in the urine -SEs: → Nasopharyngitis → headache → acute pancreatitis → Rash (Stevens Johnson Syndrome)
Dipeptidyl Peptidase – IV inhibitors 1. Sitagliptin:
112
Has similar structure to GLP→stimulates GLP peptide → glucose-mediated insulin secretion - Route of administration: SC ( not effective orally) - Can slow gastric emptying time - May Postprandial glucagon secretion - ↑Beta cell proliferation
Incretin mimetics 1. Exenatide:
113
Reduce hyperglycemia by promoting glucose excretion in urine by blocking sodium- glucose linked co trasportor 2 (SGLT2) at the proximal tubules ® reduction in reabsorption of filtered glucose and increase in its excretion - Reduces sodium reabsorption and increases delivery to distal tubule ® excretion - Downregulate sympathetic activity - Lower pre- and afterload of heart - Decreases intraglomerular pressure SE: mainly UTI, hyperkalemia, hypotension
SGLT2 inhibitors Canagliflozin & dapagliflozin